Dynamically adjusted strategy in response to developments in the COVID-19 pandemic as a new normal

被引:0
作者
Weifeng Shen
机构
[1] Zhejiang University School of Medicine,Department of Emergency Medicine, the Second Affiliated Hospital
[2] Institute of Emergency Medicine,undefined
[3] Zhejiang University,undefined
来源
Globalization and Health | / 17卷
关键词
COVID-19; Pandemic; Response; Strategy; Public health;
D O I
暂无
中图分类号
学科分类号
摘要
Presently, the developments of COVID-19 situation in different countries and regions have clearly differentiated. Due to differences in resources, infrastructure, and awareness of epidemic prevention and control, capabilities for COVID-19 prevention and control in various regions have also shown a significant imbalance as the COVID-19 epidemic is entering a new normal. The objectives of this study are to provide dynamically adjusted strategies in response to developments in the COVID-19 pandemic as a new normal. In the face of the new normal, one key is normalizing epidemic prevention and control. As part of this, we should implement precise policies based on the dynamics of the COVID-19 epidemic and particular response needs. In ongoing COVID-19 prevention and control, we must pay attention to new vulnerabilities and new features in the dynamics of the epidemic. In this study, health and government officials can benefit from insights of preparing ourselves for long-term challenges and both certainties and uncertainties in a future facing COVID-19.
引用
收藏
相关论文
共 468 条
[1]  
Oberfeld B(2020)SnapShot: COVID-19 Cell 181 954-954.e1
[2]  
Achanta A(2020)Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: Interim analysis of 2 randomized clinical trials JAMA 324 951-960
[3]  
Carpenter K(2021)The emerging plasticity of SARS-CoV-2 Science. 371 1306-1308
[4]  
Chen P(2021)An action plan for pan-European defence against new SARS-CoV-2 variants Lancet. 397 469-470
[5]  
Gilette NM(2020)Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe Lancet. 396 1525-1534
[6]  
Langat P(2021)Vaccine breakthrough infections with SARS-CoV-2 variants N Engl J Med 384 2212-2218
[7]  
Xia S(2020)Genomic epidemiology of SARS-CoV-2 in Guangdong province, China Cell 181 997-1003.e9
[8]  
Duan K(2020)Risk for transportation of coronavirus disease from Wuhan to other cities in China Emerg Infect Dis 26 1049-1052
[9]  
Zhang Y(2021)Coronavirus variants are spreading in India - what scientists know so far Nature. 593 321-322
[10]  
Zhao D(2020)Beware of the second wave of COVID-19 Lancet 395 1321-1322